Cargando…

Aminoglycosides and their potential as SARS-CoV-2 antivirals

Detalles Bibliográficos
Autor principal:	Cimolai, Nevio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985687/ https://www.ncbi.nlm.nih.gov/pubmed/33780777 http://dx.doi.org/10.1016/j.mehy.2021.110559

Ejemplares similares

Solidifying diagnostics in SARS-CoV-2 research
por: Cimolai, Nevio
Publicado: (2022)

Immunophenotyping of SARS-CoV-2 and vaccine design
por: Cimolai, Nevio
Publicado: (2022)

Reanalysis of quarantine for coronavirus disease 2019 with emerging data
por: Cimolai, Nevio
Publicado: (2021)

Comparing histamine intolerance and non-clonal mast cell activation syndrome
por: Cimolai, Nevio
Publicado: (2020)

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain
por: Lens, Sabela, et al.
Publicado: (2020)

Boron enhances the antiviral activity of the curcumin against SARS-CoV-2
por: Scorei, Ion Romulus, et al.
Publicado: (2020)

The differential roles of zinc in immune responses and their potential implications in antiviral immunity against SARS-CoV-2
por: Reinhold, Dirk, et al.
Publicado: (2021)

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
por: Bojkova, Denisa, et al.
Publicado: (2022)

Inferring SARS-CoV-2 functional genomics from viral transcriptome with identification of potential antiviral drugs and therapeutic targets
por: Pan, Xu, et al.
Publicado: (2021)

5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2022)

Potential drawbacks of SARS-CoV-2 seroprevalence surveys
por: Lippi, G.
Publicado: (2021)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

SARS-CoV-2 and Legionella Co-Infection
por: Gauvin, Caitlin A., et al.
Publicado: (2023)

Potential resistance to SARS-CoV-2 infection in lysosomal storage disorders
por: Pieroni, Maurizio, et al.
Publicado: (2021)

Lingonberry polyphenols: Potential SARS‐CoV‐2 inhibitors as nutraceutical tools?
por: Pärnänen, Pirjo, et al.
Publicado: (2021)

Could the antipsychotic chlorpromazine be a potential treatment for SARS-CoV-2?
por: Nobile, B., et al.
Publicado: (2020)

SARS-CoV-2: a potential novel etiology of fulminant myocarditis
por: Chen, Chen, et al.
Publicado: (2020)

Sars-Cov-2 and risk of antiviral drug resistance
por: Vitiello, Antonio
Publicado: (2021)

On aerosol transmission of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2021)

Living evidence for SARS-CoV-2()
por: Santillan-Garcia, A.
Publicado: (2021)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

SARS‐CoV‐2 immunogenicity at the crossroads
por: Karamloo, Fariba, et al.
Publicado: (2020)

Transmission routes of SARS-CoV-2
por: Patel, Jay
Publicado: (2020)

SARS-CoV-2 and EBV coinfection()
por: García-Martínez, Francisco Javier, et al.
Publicado: (2020)

Peptide Targets to SARS-CoV-2
por: Mandal, Santi M.
Publicado: (2020)

Is SARS-CoV-2 an oncogenic virus?
por: Gómez-Carballa, Alberto, et al.
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Routes of transmission of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP()
por: Zúñiga, José, et al.
Publicado: (2021)

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
por: Pavoni, Vittorio, et al.
Publicado: (2020)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

The Complexity of Co-Infections in the Era of COVID-19
por: Cimolai, Nevio
Publicado: (2021)

A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2
por: Luan, Junwen, et al.
Publicado: (2020)

The continuum of SARS-CoV-2's neurotropism and the potential for immune-mediated neuronal injury
por: Vavougios, George D.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7iup07cgcmbvv2h1v76ssf71uv